New Fortress Energy
NFE
SilverCrest Metals
SILV
Hutchmed (China)
HCM
Dorian LPG
LPG
Precision Drilling
PDS
Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.